NCT06258525 2026-03-18
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Cedars-Sinai Medical Center
Phase 2 Not yet recruiting
Clinical Trials
10 trialsNCT06075030 2026-02-27
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
Kind Pharmaceuticals LLC
Phase 2 Not yet recruiting
NCT06075043 2026-02-27
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
Kind Pharmaceuticals LLC
Phase 2 Not yet recruiting
NCT07408648 2026-02-13
A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Not yet recruiting
NCT07214064 2025-10-09
Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation
University Hospital Tuebingen
Phase 2 Not yet recruiting
NCT06898983 2025-03-28
Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia
Anhui Provincial Hospital
Phase 2 Not yet recruiting
NCT06854276 2025-03-03
Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2 Not yet recruiting
NCT06745219 2024-12-20
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT06143735 2023-11-22
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT05220800 2022-03-03
NAIDIC
Zealand University Hospital
Phase 2 Not yet recruiting